Harvard Bioscience (HBIO) Income from Non-Controlling Interests (2013 - 2020)
Harvard Bioscience (HBIO) posted quarterly Income from Non-Controlling Interests of $92000.0 for Q3 2020, up 324.39% year-over-year from $21678.2 in Q4 2019, and up 936.36% quarter-over-quarter from -$11000.0 in Q2 2020.
Harvard Bioscience (HBIO) Income from Non-Controlling Interests (2013 - 2020) Analysis & Trends
Harvard Bioscience (HBIO) has reported Income from Non-Controlling Interests for 8 consecutive years, with $92000.0 the latest figure, recorded in Q3 2020.
- In Q3 2020, Income from Non-Controlling Interests rose 324.39% year-over-year to $92000.0; the TTM figure through Sep 2020 stood at -$176000.0 (up 65.62% YoY), while the FY2018 annual figure was $31000.0, up 520.0% from the prior year.
- Income from Non-Controlling Interests improved to $92000.0 in Q3 2020 per HBIO's latest filing, from -$11000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $155000.0 in Q2 2018 and bottomed at -$279000.0 in Q2 2019.
- Historically, Income from Non-Controlling Interests has averaged -$40750.0 across 5 years, with a median of -$11500.0 in 2016.
- Annual changes were most pronounced in 2018 — Income from Non-Controlling Interests plunged 6450.0% — and 2020, when it surged 324.39%.
- Harvard Bioscience's Income from Non-Controlling Interests stood at $11000.0 in 2016, then jumped by 754.55% to $94000.0 in 2017, then tumbled by 95.74% to $4000.0 in 2018, then slumped by 1125.0% to -$41000.0 in 2019, then soared by 324.39% to $92000.0 in 2020.
- Business Quant data shows HBIO's Income from Non-Controlling Interests at $92000.0 in Q3 2020, -$11000.0 in Q2 2020, and -$216000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 92,000.00 |
| Jun 30, 2020 | -11,000.00 |
| Mar 31, 2020 | -216,000.00 |
| Sep 30, 2019 | -41,000.00 |
| Jun 30, 2019 | -279,000.00 |
| Mar 31, 2019 | -196,000.00 |
| Dec 31, 2018 | 4,000.00 |
| Sep 30, 2018 | 126,000.00 |
| Jun 30, 2018 | 155,000.00 |
| Mar 31, 2018 | -254,000.00 |
| Dec 31, 2017 | 94,000.00 |
| Jun 30, 2017 | -93,000.00 |
| Mar 31, 2017 | 4,000.00 |
| Sep 30, 2016 | 11,000.00 |
| Jun 30, 2016 | -12,000.00 |
| Mar 31, 2016 | -36,000.00 |
| Sep 30, 2015 | -39,000.00 |
| Jun 30, 2015 | -12,000.00 |
| Mar 31, 2015 | -59,000.00 |
| Sep 30, 2014 | 23,000.00 |